Jonathan Rivinus

Cooley advised Printify, a technology platform headquartered in Latvia that makes it possible for anyone, anywhere, to sell customized products with zero upfront investment, on its merger with Printful, a Latvia-based technology company that helps ecommerce sellers of all sizes use production-on-demand and other fulfillment solutions to turn their ideas into brands and products.

Cooley advised Chimagen Biosciences, a privately held biotechnology company, on its agreement to sell CMG1A46, a clinical-stage dual CD19 and CD20-targeted T-cell engager (TCE), to GSK, a global biopharma company, for an upfront payment of $300 million, plus success-based development and commercial milestone payments totaling up to $550 million.

Cooley advised Encord, a data development platform for multimodal artificial intelligence, on its $30 million Series B financing.

Cooley advised Spring Health, the top global mental health solution for employers and health plans, on its $100 million Series E financing with a valuation of $3.3 billion.

Cooley advised First Street, the standard in physical climate risk data, on its oversubscribed Series A-1 financing.